BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 18166787)

  • 1. Tumor lysis syndrome in patients with acute myeloid leukemia: identification of risk factors and development of a predictive model.
    Montesinos P; Lorenzo I; Martín G; Sanz J; Pérez-Sirvent ML; Martínez D; Ortí G; Algarra L; Martínez J; Moscardó F; de la Rubia J; Jarque I; Sanz G; Sanz MA
    Haematologica; 2008 Jan; 93(1):67-74. PubMed ID: 18166787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Features at presentation predict children with acute lymphoblastic leukemia at low risk for tumor lysis syndrome.
    Truong TH; Beyene J; Hitzler J; Abla O; Maloney AM; Weitzman S; Sung L
    Cancer; 2007 Oct; 110(8):1832-9. PubMed ID: 17724682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute tumor lysis syndrome in solid tumors--a case report and review of the literature.
    Baeksgaard L; Sørensen JB
    Cancer Chemother Pharmacol; 2003 Mar; 51(3):187-92. PubMed ID: 12655435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor lysis syndrome in children with non-Hodgkin lymphoma.
    Alavi S; Arzanian MT; Abbasian MR; Ashena Z
    Pediatr Hematol Oncol; 2006; 23(1):65-70. PubMed ID: 16326415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A scoring system to predict the risk of death during induction with anthracycline plus cytarabine-based chemotherapy in patients with de novo acute myeloid leukemia.
    Valcárcel D; Montesinos P; Sánchez-Ortega I; Brunet S; Esteve J; Martínez-Cuadrón D; Ribera JM; Tormo M; Bueno J; Duarte R; Llorente A; Torres JP; Guardia R; Sanz MA; Sierra AJ;
    Cancer; 2012 Jan; 118(2):410-7. PubMed ID: 21717435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of tumor lysis syndrome in children with advanced stage Burkitt's lymphoma/leukemia before and after introduction of prophylactic use of urate oxidase.
    Wössmann W; Schrappe M; Meyer U; Zimmermann M; Reiter A
    Ann Hematol; 2003 Mar; 82(3):160-5. PubMed ID: 12634948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute spontaneous tumor lysis presenting with hyperuricemic acute renal failure: clinical features and therapeutic approach.
    Hsu HH; Chan YL; Huang CC
    J Nephrol; 2004; 17(1):50-6. PubMed ID: 15151259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A predictive model for the detection of tumor lysis syndrome during AML induction therapy.
    Mato AR; Riccio BE; Qin L; Heitjan DF; Carroll M; Loren A; Porter DL; Perl A; Stadtmauer E; Tsai D; Gewirtz A; Luger SM
    Leuk Lymphoma; 2006 May; 47(5):877-83. PubMed ID: 16753873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor lysis syndrome in induction therapy for acute myeloid leukemia before the rasburicase era.
    Toda Y; Ashizawa M; Murahashi R; Nakashima H; Ikeda T; Kawaguchi SI; Nagayama T; Umino K; Minakata D; Morita K; Yamamoto C; Hatano K; Sato K; Fujiwara SI; Ohmine K; Kanda Y
    Int J Hematol; 2024 Jun; 119(6):660-666. PubMed ID: 38575822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical versus laboratory tumor lysis syndrome in children with acute leukemia.
    Kedar A; Grow W; Neiberger RE
    Pediatr Hematol Oncol; 1995; 12(2):129-34. PubMed ID: 7626380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of risk-adapted therapy in acute myeloid leukaemia. A long-term population-based follow-up study.
    Wahlin A; Billström R; Björ O; Ahlgren T; Hedenus M; Höglund M; Lindmark A; Markevärn B; Nilsson B; Sallerfors B; Brune M
    Eur J Haematol; 2009 Aug; 83(2):99-107. PubMed ID: 19385987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of leukapheresis on early death rate in adult acute myeloid leukemia presenting with hyperleukocytosis.
    Bug G; Anargyrou K; Tonn T; Bialleck H; Seifried E; Hoelzer D; Ottmann OG
    Transfusion; 2007 Oct; 47(10):1843-50. PubMed ID: 17880610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of serum sodium in assessing hospital mortality in cancer patients with spontaneous tumour lysis syndrome inducing acute uric acid nephropathy.
    Hsu HH; Chen YC; Tian YC; Chan YL; Kuo MC; Tang CC; Fang JT; Lee SY; Yang CW
    Int J Clin Pract; 2009 May; 63(5):751-6. PubMed ID: 19402210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus.
    Cairo MS; Coiffier B; Reiter A; Younes A;
    Br J Haematol; 2010 May; 149(4):578-86. PubMed ID: 20331465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors and decision criteria for intensive chemotherapy in older patients with acute myeloid leukemia.
    Malfuson JV; Etienne A; Turlure P; de Revel T; Thomas X; Contentin N; Terré C; Rigaudeau S; Bordessoule D; Vey N; Gardin C; Dombret H;
    Haematologica; 2008 Dec; 93(12):1806-13. PubMed ID: 18838471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An integrated clinical approach for the identification, prevention, and treatment of tumor lysis syndrome.
    Mughal TI; Ejaz AA; Foringer JR; Coiffier B
    Cancer Treat Rev; 2010 Apr; 36(2):164-76. PubMed ID: 20031331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tumor lysis syndrome].
    Hagino T
    Gan To Kagaku Ryoho; 2010 Jun; 37(6):984-8. PubMed ID: 20567098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-related risk profile and chemotherapy dose response in acute myeloid leukemia: a study by the German Acute Myeloid Leukemia Cooperative Group.
    Büchner T; Berdel WE; Haferlach C; Haferlach T; Schnittger S; Müller-Tidow C; Braess J; Spiekermann K; Kienast J; Staib P; Grüneisen A; Kern W; Reichle A; Maschmeyer G; Aul C; Lengfelder E; Sauerland MC; Heinecke A; Wörmann B; Hiddemann W
    J Clin Oncol; 2009 Jan; 27(1):61-9. PubMed ID: 19047294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is International Prognostic Scoring System (IPSS) still standard in predicting prognosis in patients with myelodysplastic syndrome? External validation of the WHO Classification-Based Prognostic Scoring System (WPSS) and comparison with IPSS.
    Park MJ; Kim HJ; Kim SH; Kim DH; Kim SJ; Jang JH; Kim K; Kim WS; Jung CW
    Eur J Haematol; 2008 Nov; 81(5):364-73. PubMed ID: 18637029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of continuous venovenous hemofiltration with chemotherapy in patients with Burkitt lymphoma and leukemia at high risk of tumor lysis syndrome.
    Choi KA; Lee JE; Kim YG; Kim DJ; Kim K; Ko YH; Oh HY; Kim WS; Huh W
    Ann Hematol; 2009 Jul; 88(7):639-45. PubMed ID: 19030857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.